प्रोटॉन पंप अवरोधकों के लिए ओमेप्राज़ोल संश्लेषण

काइरल चयनात्मक रसायन के साथ गैस्ट्रिक अम्ल को नियंत्रित करना

Pharmaceutical & Drug Manufacturing Global Industrial Scale $3.5 billion

अवलोकन

Omeprazole is the first proton pump inhibitor (PPI) to reach the market and remains one of the most prescribed medications globally for treating gastric acid disorders, peptic ulcers, and GERD. The synthesis involves a multi-step process building the benzimidazole-pyridine core structure. The chiral version, esomeprazole (the S-enantiomer), represents a significant pharmaceutical advancement, produced using an asymmetric oxidation that won AstraZeneca substantial patent protection.

रासायनिक प्रक्रिया

2-Chloromethyl-3,5-dimethyl-4-methoxypyridine is coupled with 5-methoxy-2-mercaptobenzimidazole to form the thioether intermediate. Selective oxidation with m-CPBA or titanium-mediated asymmetric oxidation yields the sulfoxide drug substance.

Thioether intermediate + m-CPBA → Omeprazole (sulfoxide)
For esomeprazole: Ti(OiPr)₄/(R,R)-DET/cumene hydroperoxide → S-omeprazole (>99.5% ee)

कच्चा माल

  • 5-Methoxy-2-mercaptobenzimidazole — Multi-step synthesis from o-phenylenediamine (Core structure)
  • 2-Chloromethyl-3,5-dimethyl-4-methoxypyridine — Pyridine chemistry (Pyridine moiety)
  • m-CPBA (meta-chloroperoxybenzoic acid) — Chemical synthesis (Oxidizing agent)

अंतिम उत्पाद

  • Omeprazole (C₁₇H₁₉N₃O₃S) — Proton pump inhibitor for GERD and ulcers (Racemic or enantiopure form)
<path stroke-linecap="round" stroke-linejoin="round" d="M12 9v3.75m-9.303 3.376c-.866 1.5.217 3.374 1.948 3.374h14.71c1.73 0 2.813-1.874 1.948-3.374L13.949 3.378c-.866-1.5-3.032-1.5-3.898 0L2.697 16.126zM12 15.75h.007v.008H12v-.008z" />

Environmental Impact

Multi-step synthesis generates significant organic waste including halogenated solvents. m-CPBA oxidation produces m-chlorobenzoic acid waste. Modern production increasingly uses catalytic oxidation methods and solvent recycling to minimize environmental impact.

सुरक्षा संबंधी विचार

हालिया नवाचार

Biocatalytic oxidation using engineered cytochrome P450 enzymes and Baeyer-Villiger monooxygenases offers enantioselective sulfoxidation under mild conditions, potentially replacing chemical oxidants entirely.

उत्पादन पैमाना

800

टन/वर्ष

$3.5 billion

बाज़ार मूल्य

%(name)s में और Pharmaceutical & Drug Manufacturing

आइबुप्रोफेन संश्लेषण — BHC हरित प्रक्रिया

Global Industrial Scale

एमोक्सिसिलिन अर्ध-सिंथेटिक उत्पादन

Global Industrial Scale

किण्वन द्वारा पेनिसिलिन G उत्पादन

Global Industrial Scale

पुनर्संयोजक मानव इंसुलिन उत्पादन

Global Industrial Scale

पेरासिटामोल (एसिटामिनोफेन) संश्लेषण

Global Industrial Scale

मेटफॉर्मिन हाइड्रोक्लोराइड संश्लेषण

Global Industrial Scale

सैलिसिलिक अम्ल के एसिटाइलेशन द्वारा एस्पिरिन संश्लेषण

Global Industrial Scale

Frequently Asked Questions

What industry uses प्रोटॉन पंप अवरोधकों के लिए ओमेप्राज़ोल संश्लेषण?
प्रोटॉन पंप अवरोधकों के लिए ओमेप्राज़ोल संश्लेषण is used in the pharmaceutical & drug manufacturing sector at global industrial scale scale.
What process is involved in प्रोटॉन पंप अवरोधकों के लिए ओमेप्राज़ोल संश्लेषण?
2-Chloromethyl-3,5-dimethyl-4-methoxypyridine is coupled with 5-methoxy-2-mercaptobenzimidazole to form the thioether intermediate. Selective oxidation with m-CPBA or titanium-mediated asymmetric oxidation yields the sulfoxide drug substance.
What is the economic significance of प्रोटॉन पंप अवरोधकों के लिए ओमेप्राज़ोल संश्लेषण?
प्रोटॉन पंप अवरोधकों के लिए ओमेप्राज़ोल संश्लेषण has a market value of $3.5 billion and annual production of 800 tons.
What is the environmental impact of प्रोटॉन पंप अवरोधकों के लिए ओमेप्राज़ोल संश्लेषण?
Multi-step synthesis generates significant organic waste including halogenated solvents. m-CPBA oxidation produces m-chlorobenzoic acid waste. Modern production increasingly uses catalytic oxidation methods and solvent recycling to minimize environmental impact.
What raw materials are used in प्रोटॉन पंप अवरोधकों के लिए ओमेप्राज़ोल संश्लेषण?
The main raw materials include: 5-Methoxy-2-mercaptobenzimidazole, 2-Chloromethyl-3,5-dimethyl-4-methoxypyridine, m-CPBA (meta-chloroperoxybenzoic acid).